Sort   by:  
 Page size 
UnknownSeven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
Not available
S-EPMC3478574 | biostudies-literature
UnknownDefinitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
Not available
S-EPMC3757290 | biostudies-literature
UnknownLong-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
Not available
S-EPMC5721228 | biostudies-literature
UnknownFindings and Recommendations From the State of the Art (SOTA) Conference on Nursing Research to Improve Veteran Outcomes.
Not available
S-EPMC12685319 | biostudies-literature
UnknownFinal, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma.
Not available
S-EPMC12080919 | biostudies-literature
UnknownSurgical site infection after gastrointestinal surgery in children: an international, multicentre, prospective cohort study.
Not available
S-EPMC7716674 | biostudies-literature
UnknownImpact of postoperative acute kidney injury in patients undergoing major gastrointestinal surgery on 1-year survival and renal outcomes: a national multicentre cohort study.
Not available
S-EPMC8759520 | biostudies-literature
Sort   by:  
 Page size